Pharmacokinetic/Pharmacodynamic Modeling of Schedule-Dependent Interaction Between Docetaxel and Cabozantinib in Human Prostate Cancer Xenograft Models

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.117.243931
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models After Administration of Anticancer Agents

Cancer Research
Cancer ResearchOncology
2004English

Time-Dependent Pharmacokinetics of Dexamethasone and Its Efficacy in Human Breast Cancer Xenograft Mice: A Semi-Mechanism-Based Pharmacokinetic/Pharmacodynamic Model

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Evaluation of the Pharmacodynamic and Pharmacokinetic Interaction Between Pagoclone and Ethanol.

Clinical Pharmacology and Therapeutics
Pharmacology
2003English

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

New Sampling Techniques for Pharmacokinetic- Pharmacodynamic Modeling

2012English

Population Pharmacokinetic-Pharmacodynamic Modeling of Captopril in Healthy Volunteers

Journal of Korean Society for Clinical Pharmacology and Therapeutics
2001English

Pharmacokinetic–Pharmacodynamic Modeling of Enrofloxacin Against Escherichia Coli in Broilers

Frontiers in Veterinary Science
Veterinary
2016English

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy